How long should I stop taking metformin (for weight loss) before glucose testing during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Long to Stop Metformin Before Glucose Testing During Pregnancy

You should stop taking metformin at least 24-48 hours before undergoing glucose testing during pregnancy to avoid false results that could affect proper diagnosis of gestational diabetes mellitus (GDM).

Understanding Gestational Diabetes Testing

  • Glucose testing during pregnancy is typically performed between 24-28 weeks of gestation for women not previously diagnosed with diabetes 1
  • Two main approaches are used for GDM screening:
    • One-step approach: 75g oral glucose tolerance test (OGTT) with measurements taken fasting, at 1 hour, and 2 hours 1
    • Two-step approach: Initial 50g glucose challenge test (GCT, non-fasting) followed by a 100g OGTT if screening is positive 1

Why Metformin Should Be Temporarily Discontinued

  • Metformin improves insulin sensitivity and lowers blood glucose levels, which could mask underlying glucose intolerance during testing 2
  • For accurate diagnostic results, the OGTT should be performed after an overnight fast of at least 8 hours and after at least 3 days of unrestricted diet (≥150g carbohydrate per day) 1
  • While specific guidelines don't explicitly state metformin washout periods for GDM testing, clinical practice suggests stopping metformin 24-48 hours before testing to prevent interference with results

Testing Procedure Requirements

  • The glucose tolerance test should be performed in the morning after an overnight fast of 8-14 hours 1
  • During the test, you should remain seated and not smoke throughout the procedure 1
  • For the one-step approach (75g OGTT), the diagnosis of GDM is made when any of these values are met or exceeded:
    • Fasting: ≥92 mg/dL (5.1 mmol/L)
    • 1-hour: ≥180 mg/dL (10.0 mmol/L)
    • 2-hour: ≥153 mg/dL (8.5 mmol/L) 1

Special Considerations for Your Situation

  • Since you've been taking metformin for weight loss and not for pre-existing diabetes, it's important to get an accurate assessment of your glucose metabolism during pregnancy 3
  • Metformin crosses the placenta, and while some studies suggest it may be safe during pregnancy, it is not FDA-approved as first-line therapy for GDM 3, 4
  • After testing, discuss with your healthcare provider whether to resume metformin based on your test results and individual circumstances

After Testing

  • If GDM is diagnosed, initial treatment typically includes dietary modifications, physical activity, and glucose monitoring 1
  • If you're diagnosed with GDM and lifestyle modifications aren't sufficient, your provider may recommend insulin as the preferred pharmacological treatment 3
  • Women with GDM should be tested for diabetes or prediabetes at 4-12 weeks postpartum using a 75g OGTT 1

Common Pitfalls to Avoid

  • Not stopping metformin before testing could lead to falsely normal results and missed diagnosis of GDM
  • Failing to follow the fasting requirements (8-14 hours) could invalidate test results 1
  • Remember that even if you've been taking metformin for weight management, you still need proper screening for GDM as per standard guidelines 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metformin - a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2017

Guideline

Insulin Therapy for Obese Women with Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.